Your browser doesn't support javascript.
loading
Developing and validating polygenic risk scores for colorectal cancer risk prediction in East Asians.
Ping, Jie; Yang, Yaohua; Wen, Wanqing; Kweon, Sun-Seog; Matsuda, Koichi; Jia, Wei-Hua; Shin, Aesun; Gao, Yu-Tang; Matsuo, Keitaro; Kim, Jeongseon; Kim, Dong-Hyun; Jee, Sun Ha; Cai, Qiuyin; Chen, Zhishan; Tao, Ran; Shin, Min-Ho; Tanikawa, Chizu; Pan, Zhi-Zhong; Oh, Jae Hwan; Oze, Isao; Ahn, Yoon-Ok; Jung, Keum Ji; Ren, Zefang; Shu, Xiao-Ou; Long, Jirong; Zheng, Wei.
Afiliação
  • Ping J; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Yang Y; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Wen W; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Kweon SS; Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, South Korea.
  • Matsuda K; Laboratory of Clinical Genome Sequencing, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo, Japan.
  • Jia WH; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China.
  • Shin A; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.
  • Gao YT; Cancer Research Institute, Seoul National University, Seoul, South Korea.
  • Matsuo K; State Key Laboratory of Oncogenes and Related Genes and Department of Epidemiology, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Kim J; Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Kim DH; Department of Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Jee SH; Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Gyeonggi-do, South Korea.
  • Cai Q; Department of Social and Preventive Medicine, Hallym University College of Medicine, Okcheon-dong, South Korea.
  • Chen Z; Department of Epidemiology and Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, South Korea.
  • Tao R; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Shin MH; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Tanikawa C; Department of Biostatistics, Vanderbilt University, Nashville, Tennessee, USA.
  • Pan ZZ; Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, South Korea.
  • Oh JH; Laboratory of Genome Technology, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
  • Oze I; State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University, Guangzhou, China.
  • Ahn YO; Center for Colorectal Cancer, National Cancer Center Hospital, National Cancer Center, Gyeonggi-do, South Korea.
  • Jung KJ; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan.
  • Ren Z; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, South Korea.
  • Shu XO; Department of Epidemiology and Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, South Korea.
  • Long J; School of Public Health, Sun Yat-sen University, Guangzhou, China.
  • Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
Int J Cancer ; 151(10): 1726-1736, 2022 11 15.
Article em En | MEDLINE | ID: mdl-35765848
ABSTRACT
Several polygenic risk scores (PRSs) have been developed to predict the risk of colorectal cancer (CRC) in European descendants. We used genome-wide association study (GWAS) data from 22 702 cases and 212 486 controls of Asian ancestry to develop PRSs and validated them in two case-control studies (1454 Korean and 1736 Chinese). Eleven PRSs were derived using three approaches GWAS-identified CRC risk SNPs, CRC risk variants identified through fine-mapping of known risk loci and genome-wide risk prediction algorithms. Logistic regression was used to estimate odds ratios (ORs) and area under the curve (AUC). PRS115-EAS , a PRS with 115 GWAS-reported risk variants derived from East-Asian data, validated significantly better than PRS115-EUR derived from European descendants. In the Korea validation set, OR per SD increase of PRS115-EAS was 1.63 (95% CI = 1.46-1.82; AUC = 0.63), compared with OR of 1.44 (95% CI = 1.29-1.60, AUC = 0.60) for PRS115-EUR . PRS115-EAS/EUR derived using meta-analysis results of both populations slightly improved the AUC to 0.64. Similar but weaker associations were found in the China validation set. Individuals among the highest 5% of PRS115-EAS/EUR have a 2.52-fold elevated CRC risk compared with the medium (41-60th) risk group and have a 12% to 20% risk of developing CRC by age 85. PRSs constructed using results from fine-mapping and genome-wide algorithms did not perform as well as PRS115-EAS and PRS115-EAS/EUR in risk prediction, possibly due to a small sample size. Our results indicate that CRC PRSs are promising in predicting CRC risk in East Asians and highlights the importance of using population-specific data to build CRC risk prediction models.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Estudo de Associação Genômica Ampla Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged80 / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Estudo de Associação Genômica Ampla Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Aged80 / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article